首页> 美国卫生研究院文献>Cancer Medicine >Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy

【2h】

Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy

机译：晚期胰腺癌姑息化疗患者预后模型的验证与应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWe previously developed a robust prognostic model (GS model) to predict the survival outcome of patients with advanced pancreatic cancer (APC) receiving palliative chemotherapy with gemcitabine plus S‐1 (GS). This study aimed to validate the application of the GS model in APC patients receiving chemotherapy other than the GS regimen.

机译：背景我们之前曾开发过一种健壮的预后模型（GS模型），以预测接受吉西他滨加S-1（GS）姑息化疗的晚期胰腺癌（APC）患者的生存结果。本研究旨在验证GS模型在接受GS方案以外的化疗的APC患者中的应用。

著录项

期刊名称 Cancer Medicine
作者
Pei‐Wei Huang; Ching‐Fu Chang; Chia‐Yen Hung; Shun‐Wen Hsueh; Pei‐Hung Chang; Kun‐Yun Yeh; Jen‐Shi Chen; Yen‐Yang Chen; Chang‐Hsien Lu; Yu‐Shin Hung; Wen‐Chi Chou;
展开▼
作者单位

展开▼
年(卷),期 2019(8),12
年度 2019
页码 5554–5563
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
palliative chemotherapy pancreatic cancer prognostic model;

机译：姑息性化疗;胰腺癌;预后模型;

相似文献

外文文献
中文文献
专利

1. Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy [J] . Pei‐Wei Huang, Ching‐Fu Chang, Chia‐Yen Hung, Cancer Medicine . 2019,第12期

机译：高级胰腺癌接受姑息化疗患者预后模型的验证与应用
2. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy [J] . Kou Tadayuki, Kanai Masashi, Yamamoto Michio, International journal of clinical oncology . 2016,第1期

机译：基于现成的预处理因素的晚期胰腺癌姑息化疗患者生存预后模型
3. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: Results from a multicenter, pooled analysis of patients receiving palliative chemotherapy [J] . HaasM., HeinemannV., KullmannF., Journal of Cancer Research and Clinical Oncology . 2013,第4期

机译：CA 19-9，CEA，CRP，LDH和胆红素水平在局部晚期和转移性胰腺癌中的预后价值：多中心汇总分析接受姑息化疗患者的结果
4. A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy [C] . Mazzocco Thomas, Hussain Amir 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services . 2011

机译：肺癌，结直肠癌和乳腺癌患者接受化疗的副作用映射模型
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy [O] . Peng Xue, Lifei Zhu, Zhiyong Wan, -1

机译：预后指数模型可预测姑息化疗后晚期胰腺癌患者的临床结局
7. Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy [O] . Pei‐Wei Huang, Ching‐Fu Chang, Chia‐Yen Hung, 2019

机译：高级胰腺癌接受姑息化疗患者预后模型的验证与应用

Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅